These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 22874)

  • 1. [Selective toxicity of new carcinostatic transport forms produced by exogenous enzymes. 1. 6-mercaptopurine-S-beta-D-xyloparanoside and beta-xylopyranosidase].
    Tschiersch B; Schwabe K; Graffi A
    Pharmazie; 1977; 32(8-9):465-7. PubMed ID: 22874
    [No Abstract]   [Full Text] [Related]  

  • 2. [Selective variations in toxicity of new transport forms of carcinostatics produced by exogenous enzymes. 2. Beta-peltatin A-alpha-L-arabinofuranoside and alpha-L-arabinofuranosidase].
    Tschiersch B; Schwabe K; Sydow G; Graffi A
    Pharmazie; 1978 Jun; 33(6):358-61. PubMed ID: 28536
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective tumor DNA synthesis inhibition: in vivo prodrug activation by an exogenous enzyme.
    Tschiersch B; Schwabe K; Sydow G; Graffi A
    Cancer Treat Rep; 1977 Nov; 61(8):1489-93. PubMed ID: 21745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enzymatically cleavable specific transport forms of cancerostatics. 3. 4-/N.N-bis-(2-chlorethyl)-amino/-derivatives of phenyl-O-beta-D-cellobiosids and pyrocatechol-bis-/O-beta-D-cellobiosids].
    Schwabe K; Graffi A; Redslob J; Hülsmann W; Butschak G
    Pharmazie; 1976 Jul; 31(7):438-41. PubMed ID: 981295
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preparation of 6-mercaptopurine glucuronides. 1. CMT selection--syntheses].
    Oehlke J
    Pharmazie; 1978 May; 33(5):250-3. PubMed ID: 674330
    [No Abstract]   [Full Text] [Related]  

  • 6. [The preparation and properties of glycosides with cytotoxic aglycones and disaccharides in the sugar moiety].
    Arndt D; Hülsmann W; Tschiersch B
    Pharmazie; 1978 May; 33(5):248-50. PubMed ID: 674329
    [No Abstract]   [Full Text] [Related]  

  • 7. Further studies on the metabolic effects of 9-beta-D-arabinofuranosyl-9-H-purine-6-thiol.
    Kimball AP; LePage GA; Allinson PS
    Cancer Res; 1967 Jan; 27(1):106-16. PubMed ID: 6066998
    [No Abstract]   [Full Text] [Related]  

  • 8. [Principles of cancer chemotherapy from an experimental aspect].
    Tschiersch B
    Pharmazie; 1974; 29(10-11):652-6. PubMed ID: 4438406
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of toxicity, immunodepressive and tolerogenic activity of thiamiprine, azathioprine and cyclophosphane].
    Filitis LN; Sorkina IuA; Pershin GN; Pevnitskiĭ LA; Solov'ev VV
    Farmakol Toksikol; 1971; 34(6):708-13. PubMed ID: 5139795
    [No Abstract]   [Full Text] [Related]  

  • 10. Substances with antineoplastic activity. XCVI. Some pharmacological properties and therapeutic synergism of 6-purinyl-N-(2-chloroethyl)thiocarbamate with cytosine arabinoside.
    Mĕlka M; Krepelka J; Miko M; Pokorná S; Kejhová I; Reichlová R; Beitová M; Grimová J; Kargerová A; Sedivá J
    Neoplasma; 1989; 36(4):419-25. PubMed ID: 2671756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Flexible-chain 6-mercaptopurine-protein conjugates. 18. Immunosuppressive-antigen conjugates].
    Nuhn P; Matthes K; Wagner G; Malberg K; Schimke R; Ambrosius H
    Pharmazie; 1977 Nov; 32(11):684-7. PubMed ID: 565057
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of toxic doses of antineoplastic agents on cellular composition of porous connective tissue of mice].
    Rozenberg IB
    Farmakol Toksikol; 1970; 33(2):212-6. PubMed ID: 5425631
    [No Abstract]   [Full Text] [Related]  

  • 13. Experiments to increase the selectivity of tumor chemotherapy by means of in vivo activation of transport forms of cancerostatics by exogenous enzymes.
    Graffi A; Arnold W; Sydow G; Schwabe K; Arndt D; Pehl E
    Neoplasma; 1978; 25(4):377-84. PubMed ID: 29245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Various aspects of the problem of selectivity in the chemotherapy of cancer].
    Velousova AK
    Vopr Onkol; 1969; 15(8):96-110. PubMed ID: 4901626
    [No Abstract]   [Full Text] [Related]  

  • 15. [5'-desoxy-5'-fluorothymidine, a new inhibitor of the DNA synthesis].
    Langen P; Kowollik G
    Acta Biol Med Ger; 1968; 20(3):417-9. PubMed ID: 5755159
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of biosynthetic processes in P388 and Ehrlich ascites cells by cloturin.
    Miko M; Krepelka J; Melka M
    Drugs Exp Clin Res; 1988; 14(9):575-80. PubMed ID: 3229320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory effect of tempol on toxicity and antitumor activity of 6-mercaptopurine and on P450 cytochrome level.
    Konovalova NP; Diatchkovskaya RF; Volkova LM; Varfolomeev VN
    Neoplasma; 1996; 43(5):341-6. PubMed ID: 8996555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel derivatives of 6-mercaptopurine: synthesis, characterization and antiproliferative activities of S-allylthio-mercaptopurines.
    Miron T; Arditti F; Konstantinovski L; Rabinkov A; Mirelman D; Berrebi A; Wilchek M
    Eur J Med Chem; 2009 Feb; 44(2):541-50. PubMed ID: 18467007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [6-mercaptopurine-protein conjugates prepared by reductive alkylation. 15. Immunosuppressive antigen conjugates].
    Nuhn P; Schilling E; Wagner G; Hemmerling J; Malberg K; Schimke R; Stülpner H; Ambrosius H
    Pharmazie; 1977 Oct; 32(10):558-61. PubMed ID: 607209
    [No Abstract]   [Full Text] [Related]  

  • 20. [Synthesis and biochemical properties of heterocyclic thioethers of 2-chloro-6-mercaptopurine].
    Niebch G; Schneider F
    Z Naturforsch B Anorg Chem Org Chem Biochem Biophys Biol; 1972 Jun; 27(6):675-82. PubMed ID: 4403589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.